You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Mallinckrodt
AstraZeneca
Harvard Business School
Dow

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Vestipitant

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Vestipitant?

Vestipitant is an investigational drug.

There have been 6 clinical trials for Vestipitant. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2006.

The most common disease conditions in clinical trials are Anxiety Disorders, Vomiting, and Postoperative Nausea and Vomiting. The leading clinical trial sponsors are GlaxoSmithKline, Accenture, and [disabled in preview].

Recent Clinical Trials for Vestipitant
TitleSponsorPhase
A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)AccenturePhase 2
Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV)AccenturePhase 1
Vestipitant 28-day Tolerance StudyGlaxoSmithKlinePhase 2

See all Vestipitant clinical trials

Clinical Trial Summary for Vestipitant

Top disease conditions for Vestipitant
Top clinical trial sponsors for Vestipitant

See all Vestipitant clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Mallinckrodt
AstraZeneca
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.